Company intelligence / Profile preview
GL Pharm Tech Corp
Seongnam-si, Gyeonggi-do, South Koreaglpt.co.kr ↗
- Ownership
- Private
- Employees
- ~27
- Development stage
- Other
01
Overview
The company has commercial products including Cabalin CR extended-release tablet, Jample Ibufen syrup, Gisoren tablets, and Genstring Troki. They also have a new molecule entity pipeline for dry eye disease in development.[1][3]
- Therapeutic areas
- GastroenterologyPulmonologyCardiovascularMen's HealthEndocrinologyImmunologyNeurologyInfectious Diseases
- Modalities
- Small moleculesGeneric drugsIncrementally Modified Drugs (IMD)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Beyond the preview
Go deeper on GL Pharm Tech Corp.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GL Pharm Tech Corp.